Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-20-026647)

Filing Details

Accession Number:: 0001140361-20-026647
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-25 19:27:07
Reporting Period:: 2020-11-19

Accepted Time:: 2020-11-25 19:27:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1228627	Ocuphire Pharma Inc.	OCUP	Pharmaceutical Preparations (2834)	113516358

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830296	Sean Ainsworth	C/O Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-19	8,865	$0.00	44,665	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrant (right to buy)	Acquisiton	2020-11-19	13,394	$0.00	13,394	$4.48
Common Stock	Series B Warrant (right to buy)	Acquisiton	2020-11-19	1,574	$0.00	1,574	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,394	2020-11-19	2025-11-19	No	4	P	Direct
1,574	2020-11-19	2022-01-28	No	4	P	Direct

Footnotes

The Reporting Person purchased shares, Series A Warrants and Series B Warrants as part of a private placement for an aggregate price of $50,000.
Subject to adjustment based on certain price reset provisions.